currency and banking Top

CITIC Jiantou: It maintains the "Buy" rating of Orrit, and its product line continues to expand and enrich. According to the research report of CITIC Jiantou Securities, Orrit (605116.SH) is one of the leading companies in the field of characteristic APIs in China. In recent years, the company's product line has been continuously expanded and enriched, which has promoted the continuous growth of revenue. At the same time, the company actively laid out potential areas, and at the current point of time, we think that we can see the company's follow-up multiple catalysis: 1) The preparation business continues to be heavy: the market development of diqu progesterone tablets continues to advance, and the estradiol/estradiol-diqu progesterone composite packaging tablets have been declared for listing. It is expected that the continuous enrichment of new pipelines for the follow-up preparation business will promote the company's performance growth. 2) Smegrutide API: The construction of fermentation workshop and synthesis workshop has been completed, and the expansion and release of new capacity will promote the good growth of API business. 3) Small nucleic acid business: The 100 kg commercial production line landed in September, 2004, opening up the space for subsequent growth. Maintain the "buy" rating.The public security organs that cracked down on the rectification of the "money-changing party" found that the funds involved were more than 80 billion yuan. It was learned from the press conference of the Ministry of Public Security that in May this year, the Ministry of Public Security deployed a special work to crack down on the rectification of the "money-changing party" and derivative crimes. Since the special action, it has been found that the funds involved have flowed more than 80 billion yuan. (Xinhua News Agency)Ali launched the e-commerce app "Tao" in Japan: in the future, it will expand its staff to explore the local market. On December 12, Alibaba Group held a briefing on the e-commerce app "Tao" launched for the Japanese market. The company said that it will expand its staff in the future and fully explore the Japanese market. According to reports, the APP was launched in October, selling more than 3 million kinds of goods such as clothing, groceries and digital related products. It also has the function of recommending goods by artificial intelligence (AI) according to consumers' preferences. The goods are mainly delivered from China after the consumer places an order, and arrive in Japan a few days later. (Interface News)

Ge Yu, former assistant general manager of China Xinbao Shandong Branch, was examined and investigated. The website of the State Supervision Committee of the Central Commission for Discipline Inspection reported on December 13th that according to the news of the Discipline Inspection and Supervision Team of the State Supervision Committee of the Central Commission for Discipline Inspection in China Export Credit Insurance Company and the Supervision Committee of Liaoning Provincial Commission for Discipline Inspection, Ge Yu, former member of the Party Committee and assistant general manager of Shandong Branch of China Export Credit Insurance Company, was suspected of serious violation of discipline and law. At present, he is being examined by the Discipline Inspection and Supervision Team of the State Supervision Committee of the Central Commission for Discipline Inspection in China Export Credit Insurance Company and supervised by the Supervision Committee of Dandong City, Liaoning Province.Shanghai Gold Exchange: the settlement price of NYAuTN12 contract in Shanghai New Zealand was 627.85 yuan/gram. On December 13th, Shanghai Gold Exchange issued a notice saying that NYAuTN12 contract in Shanghai New Zealand was settled on December 13th, 2024. The details of the settlement of the contract are as follows: the settlement price of NYAuTN12 contract in Shanghai New Zealand was 627.85 yuan/gram.Hengrui Pharma: SHR-2173 injection was approved for clinical trial. Hengrui Pharma announced that its subsidiary, Guangdong Hengrui Pharma Co., Ltd., received the Notice of Approval for Clinical Trial of SHR-2173 injection approved and issued by National Medical Products Administration, and agreed to carry out clinical trial. The indication is lupus nephritis. SHR-2173 injection is a therapeutic biological product independently developed by the company, and the research and development expenses have been invested about 45.03 million yuan. The period from research and development to listing of drugs is long, there are many links, and there are uncertain factors. The company will actively promote research and development projects and fulfill its information disclosure obligations.

Saudi institutions are optimistic about China's "huge investment opportunities" in the fields of health care and biotechnology. Ekta Torani, chief investment officer of Saudi KBW Venture Capital Company, recently said in Abu Dhabi, United Arab Emirates that with the increasingly close economic and trade ties between the Gulf region and China, the institution is optimistic about China's "huge investment opportunities" in the fields of health care and biotechnology.European stocks opened slightly lower, with the Stoxx 50 index in Europe down 0.1%, DAX index in Germany up 0.2%, FTSE 100 index in Britain down 0.1% and CAC 40 index in France down 0.1%.Changshu Automobile Accessories: It is planned to invest 22.8 million yuan to set up a joint venture with Antonlin Investment Co., Ltd. Changshu Automobile Accessories announced that the company plans to set up a joint venture with Antonlin Investment Co., Ltd. in Wuhu City, Anhui Province, tentatively named Wuhu Antonlin Intelligent Cockpit System Co., Ltd., with an estimated total investment of 140 million yuan, including a registered capital of 57 million yuan. The company invested 22.8 million yuan, accounting for 40% of the total share capital of Antonglin in Wuhu; Antonglin Investment Co., Ltd. contributed 34.2 million yuan, accounting for 60% of the total share capital of Antonglin in Wuhu. The establishment of the new company will expand the company's industrial layout, improve the company's comprehensive competitive strength and realize the company's strategic plan for sustainable development.